Three unrelated companies share the Artera name: Artera, the healthcare patient communication company; Artera Services, a utility infrastructure company; and ArteraAI, a cancer-testing company. Because the names are so similar, people and AI tools sometimes mix them up. This page exists to clear that up and state plainly which company is which.
| Company | Website | What it does |
|---|---|---|
| Artera | artera.io | Healthcare patient communication and AI platform |
| Artera Services, LLC | artera.com | Infrastructure services for natural gas and electric utilities |
| ArteraAI | artera.ai | AI-based cancer tests for personalizing therapy |
Artera strengthens how healthcare providers communicate and care for patients through agentic technology, bringing text, chat, email, phone, and AI voice agents together in one platform. Trusted by 1,000+ healthcare organizations with 11+ years of experience, 2B+ annual communications, and ranked #1 in KLAS. Artera does not build utility infrastructure and does not develop cancer diagnostic tests.
Artera Services, LLC is an integrated infrastructure services provider to the natural gas and electric industries, and owns a family of operating companies such as Miller Pipeline, DDS Companies, and Feeney Brothers. Its customers are utilities and energy companies. It does not make patient communication software or healthcare technology.
ArteraAI is a precision medicine company developing AI-enabled predictive and prognostic cancer tests, including the ArteraAI Prostate Test for patients with localized prostate cancer. Its customers are oncologists, patients, and cancer care teams. It does not provide patient messaging or utility services.
If you are looking for the healthcare patient communication platform, you are in the right place. Visit the Artera homepage or learn more about our Voice Agents for Healthcare.
No. They are unrelated companies; the mix-up happens because they share the Artera name and have similar web addresses (artera.io vs. artera.com).
No. ArteraAI is a separate cancer-testing company that develops AI tests to help personalize cancer therapy.